$HSTM

REBROVICK LINDA sold $174K of HSTM

REBROVICK LINDA sold 6,000 shares of HEALTHSTREAM INC (HSTM) at $29.00 ($0.17M total) on 2026-07-06 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · REBROVICK LINDA
Published Jul 7, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 7:59 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$HSTM
Neutral
medium confidence
Mentioned
$HSTM
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$HSTMNeutralLow
01

Why it matters

The only new information is the size, price, and timing of the director’s sale under a pre-arranged 10b5-1 plan; it does not include guidance, contracts, or regulatory developments.

02

Market read

Traders may note the insider sale for sentiment, but the 10b5-1 structure makes it a low-conviction catalyst.

03

What to watch

The filing does not state any change in business outlook, and the disclosed post-sale holdings (51,329 shares) may not materially alter insider exposure.

Relevance 3/10Novelty 3/10Timing: filed 2026-07-07, sale dated 2026-07-06

Background

This is an SEC Form 4 insider transaction disclosure for HealthStream (HSTM) by director Linda Rebrovick.

Company-level read

Ticker impact

$HSTMNeutralMedium confidence
Context

HealthStream director Linda Rebrovick sold 6,000 shares at $29.00 on 2026-07-06 under a 10b5-1 plan, worth about $174k.

Expected impact

Likely minimal price impact; any effect is short-lived unless accompanied by other disclosures.

Evidence & confidence

The filing is an open-market sale by a director, explicitly under a pre-arranged 10b5-1 plan, with no accompanying operational or guidance change disclosed.

Market effects

No clear sector read-through from a single director 10b5-1 sale.

None indicated.

None indicated.

Counterpoint

Because the sale is under a 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish fundamentals.

Key entities

  • HEALTHSTREAM INC

    US-listed company whose director insider sale is disclosed on Form 4.

  • REBROVICK LINDA

    Director who sold 6,000 shares at $29.00 under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles